Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 11, 2001, Pages 53-58

  Ballenger, J C ^a   Davidson, J R T ^a   Lecrubier, Y ^a   Nutt, D J ^a   Borkovec, T D ^a   Rickels, K ^a   Stein, D J ^a   Wittchen, H U ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CLOMIPRAMINE; HYDROXYZINE; HYDROXYZINE EMBONATE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY NEUROSIS; BEHAVIOR THERAPY; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DISEASE COURSE; FUNCTIONAL DISEASE; HUMAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

AGE OF ONSET; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; TREATMENT OUTCOME;

EID: 0034966575     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Generalized anxiety, disorder
2. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey
3. Generalized anxiety disorder (ICD-10) in primary care from a cross-cultural perspective: A valid diagnostic entity?
4. The epidemiology of pure and comorbid generalized anxiety disorder: A review and evaluation of recent research
5. Common mental disorders and disability across cultures: Results from the WHO Collaborative Study on Psychosocial Problems in General Health Care
6. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys
7. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey
8. Form and frequency of mental disorders across centres
9. An overview of generalised anxiety disorder: Disease state - Appropriate therapy
10. Screening for anxiety disorders: Sensitivity and specificity of the anxiety screening questionnaire (ASQ-15)
11. The nature of normal and pathological worry
12. Somatic symptoms and psychiatric disorder: An international primary care study
13. Cancer and depression
14. Development and validation of the Penn State Worry Questionnaire
15. The Penn State Worry Questionnaire: Psychometric properties and associated characteristics
16. A self-report diagnostic measure of generalized anxiety disorder
17. Cognitive-behaviour therapy for generalized anxiety in late life: An evaluative overview
18. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample
19. Explained and unexplained medical symptoms in generalized anxiety and panic disorder: Relationship to the somatoform disorders
20. The economic burden of anxiety disorders in the 1990s
21. Help-seeking for psychiatric disorders
22. Cost of anxiety disorders: Impact of comorbidity
23. Utilization of medical specialists by anxiety disorder patients
24. Comorbidity as a fundamental feature of generalised anxiety disorders: Results from the National Comorbidity Study (NCS)
25. Anxiety disorders in major depression
26. Risk factors for suicide attempts: Epidemiological evidence
27. GAD: Current treatment and costs
28. Recognition rates of GAD and depression in primary care
29. Differences between prescription and consumption of antidepressants and anxiolytics
30. Anxiety disorder
31. Paroxetine in the treatment of primary insomnia: Preliminary clinical and electroencephalogram sleep data